MAM
Patanjali launches Coronil drug for Covid2019
MUMBAI: Baba Ramdev's Patanjali launched an ayurvedic medicine for treating Covid2019 today at Patanjali Yogpeeth in Haridwar.
Earlier this month, Patanjali Ayurved managing director Acharya Balkrishna had claimed that an ayurvedic medicine developed by the company has been able to cure Covid2019 patients within five to 14 days. Patanjali Ayurved Ltd MD Acharya Balkrishna had announced the launch on Twitter on Monday evening.
"We've prepared the first ayurvedic clinically-controlled, research, evidence and trial based medicine for Covid2019. We conducted a clinical case study and clinical controlled trial and found 69 per cent patients recovered in three days and 100 per cent patients recovered in seven days," said Ramdev.
Ramdev claims that there has been 0 per cent death rate and 100 per cent recovery rate has been observed, around 69 per cent of the people recovered within six days. 100 per cent of the people has recovered thanks to the medicine made by it.
He also stated that they have done every research.
"We appointed a team of scientists after Covid2019 outbreak. Firstly, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100 per cent favourable results," Balkrishna said at the launch.
"After taking our medicine, patients recovered in five to 14 days and then tested negative. So, we can say the cure for Covid2019 is possible through Ayurveda. We are performing controlled clinical trials only. In the next four to five days, evidence and data will be released by us," he added.
The medicine has been manufactured by Haridwar’s Divya Pharmacy and Patanjali Ayurved Ltd in Haridwar, based on a joint research by Patanjali Research Institute in Haridwar and the National Institute of Medical Science, Jaipur.
MAM
Hyphen launches sunscreen campaign featuring Kriti Sanon as SPF Police
Campaign drives SPF habit; Blinkit tie-up enables instant sunscreen delivery.
MUMBAI: No SPF, no mercy Kriti Sanon is out patrolling your skincare routine. Hyphen has rolled out a new campaign film starring its Co-Founder and Chief Customer Officer Kriti Sanon, who steps into a playful alter ego as the brand’s “SPF Police”, turning sunscreen reminders into a full-blown public service announcement with a wink. The campaign kicked off with a cheeky social media tease suggesting Sanon had “stepped down” from her role, sparking chatter online before the brand revealed the twist: she hasn’t gone anywhere, she has simply taken on an additional avatar, one dedicated to ensuring people do not skip sunscreen.
The film leans into humour to drive home a serious point. In a slice-of-life setting, Sanon intercepts a gym-goer about to step out without sunscreen, promptly handing over Hyphen’s ‘All I Need Sunscreen’, which arrives instantly via Blinkit. The message is clear: forgetting SPF is no longer a valid excuse when it can be delivered in minutes.
Beyond the laughs, the campaign taps into a well-known gap in everyday skincare habits. Sunscreen, despite being one of the most recommended steps, is often the most ignored. By gamifying the reminder through an “SPF Police” persona, Hyphen aims to turn a routine into a reflex.
The multi-stage rollout from intrigue-led teasers to the final film has been designed to spark conversation while embedding the brand into daily behaviour. It also spotlights Hyphen’s quick commerce partnership with Blinkit, positioning accessibility as a key enabler of consistency.
Sanon, who remains closely involved in product development and brand strategy, noted that the idea stemmed from a simple insight: skincare works best when it is easy, habitual and hard to ignore. The campaign reflects that philosophy equal parts science, storytelling and a nudge you cannot quite escape.
The film is now live across Hyphen and Blinkit’s digital platforms, with further activations expected to extend the campaign’s reach and perhaps keep the SPF Police on duty a little longer.
